Transgene SA
TRGNF
$0.85
-$0.15-15.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -42.37M | -41.08M | -40.03M | -37.96M | -36.75M |
| Total Depreciation and Amortization | 1.50M | 1.47M | 1.46M | 1.41M | 1.39M |
| Total Amortization of Deferred Charges | -- | 692.90K | 1.41M | 1.41M | 1.41M |
| Total Other Non-Cash Items | 4.22M | 1.60M | -1.06M | -2.15M | -3.15M |
| Change in Net Operating Assets | -5.26M | 3.84M | 13.18M | 12.45M | 11.65M |
| Cash from Operations | -41.91M | -33.46M | -25.05M | -24.85M | -25.46M |
| Capital Expenditure | -961.90K | -1.20M | -1.45M | -2.38M | -3.32M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -122.60M | -61.97M | -1.10M | -620.60K | -152.50K |
| Cash from Investing | -123.56M | -63.17M | -2.55M | -3.00M | -3.47M |
| Total Debt Issued | 0.00 | 150.00K | 300.00K | 150.00K | 0.00 |
| Total Debt Repaid | -17.00K | -53.50K | -90.00K | -665.00K | -1.24M |
| Issuance of Common Stock | 105.11M | 52.61M | 111.00K | 111.00K | 111.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 29.60M | 28.52M | 27.45M | 27.77M | 28.09M |
| Cash from Financing | 155.67M | 93.06M | 30.28M | 29.26M | 29.15M |
| Foreign Exchange rate Adjustments | -1.89M | -1.50M | -1.10M | -90.40K | 864.40K |
| Miscellaneous Cash Flow Adjustments | 100.00 | -500.00 | -1.10K | -500.00 | -- |
| Net Change in Cash | -11.69M | -5.08M | 1.57M | 1.33M | 1.09M |